마이크로바이옴 시퀀싱 서비스 시장 규모, 점유율 및 성장 분석 : 서비스별, 유형별, 기술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Microbiome Sequencing Services Market size was valued at USD 288.4 Million in 2024 and is poised to grow from USD 311.18 Million in 2025 to USD 571.73 Million by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global microbiome sequencing services market is experiencing robust growth driven by advancements in genetic technology and a heightened awareness of the microbiome's role in health and personalized medicine. Increasing interest in understanding microbial communities within the human body is propelling demand for sequencing services. These services are integral to developing microbiome-based therapies for various diseases, making them essential for crafting effective treatment strategies. The integration of multi-omics approaches-combining transcriptomics, metabolomics, and genomic data with microbiome sequencing-enhances research quality and deepens insights into human-microbe interactions. Additionally, microbiome sequencing's applications extend to environmental and agricultural studies, highlighting its vast potential. The rising need for sophisticated bioinformatics solutions to analyze complex microbial genomic data further propels this burgeoning field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbiome Sequencing Services Market Segments Analysis

Global Microbiome Sequencing Services Market is segmented by Service, Type, Technology, End User and region. Based on Service, the market is segmented into Sample Preparation, Sequencing and Library Preparation and Data Analysis. Based on Type, the market is segmented into Targeted Sequencing and Whole Genome Sequencing. Based on Technology, the market is segmented into Sequencing by Synthesis, Sequencing by Ligation, Nanopore Sequencing, Pyrosequencing and Sanger Sequencing. Based on End User, the market is segmented into Pharmaceutical and Biotechnology, Academic and Research Institutes, Hospitals and Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbiome Sequencing Services Market

The expansion of the global microbiome sequencing services market is significantly influenced by the rising trend of personalized medicine. As healthcare increasingly adapts to meet the individual needs of patients, microbiome analysis becomes essential in understanding the unique composition of microorganisms present in each individual. This information is crucial for accurately diagnosing and effectively managing various health conditions. Consequently, the demand for microbiome sequencing services is on the rise, as healthcare providers seek tailored solutions to improve patient outcomes and enhance treatment strategies. This shift towards personalized approaches is driving growth in the market for microbiome analysis services.

Restraints in the Global Microbiome Sequencing Services Market

The Global Microbiome Sequencing Services market faces a notable challenge due to the elevated costs associated with microbiome sequencing services. Despite advancements in technology, the expenses related to sequencing equipment, reagents, and analytical processes often pose substantial barriers for smaller research facilities and clinics. This financial burden hinders the widespread adoption and utilization of these services, ultimately constraining the growth prospects within the industry. As a result, many potential users may be deterred from engaging with microbiome sequencing, limiting the overall expansion and innovation opportunities available in the market.

Market Trends of the Global Microbiome Sequencing Services Market

The global microbiome sequencing services market is experiencing a notable trend characterized by the rising integration of Artificial Intelligence (AI) and machine learning technologies in microbiome analysis. This advancement facilitates the enhanced interpretation of complex microbiome datasets, enabling researchers to gain deeper insights into microbial functionality and its implications for health and disease prevention. By leveraging AI algorithms, stakeholders are able to streamline data processing, uncover hidden patterns, and optimize microbiome-related therapeutic strategies. Consequently, this incorporation of cutting-edge technology not only accelerates research but also drives innovation in personalized medicine, making it a pivotal factor in shaping the future of microbiome sequencing services.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Microbiome Sequencing Services Market Size by Service & CAGR (2026-2033)

• Market Overview
• Sample Preparation
• Sequencing and Library Preparation
• Data Analysis

Global Microbiome Sequencing Services Market Size by Type & CAGR (2026-2033)

• Market Overview
• Targeted Sequencing
  • Amplicon Sequencing
  • Shotgun Sequencing
• Whole Genome Sequencing

Global Microbiome Sequencing Services Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sequencing by Synthesis
• Sequencing by Ligation
• Nanopore Sequencing
• Pyrosequencing
• Sanger Sequencing

Global Microbiome Sequencing Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnology
• Academic and Research Institutes
• Hospitals and Clinics
• Other End Users

Global Microbiome Sequencing Services Market Size & CAGR (2026-2033)

• North America (Service, Type, Technology, End User)
  • US
  • Canada
• Europe (Service, Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Type, Technology, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CHARLES RIVER LABORATORIES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROFINS SCIENTIFIC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI GROUP
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COSMOSID
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROBA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROBIOME INSIGHTS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASECLEAR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD GENOMICS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZYMO RESEARCH CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ORASURE TECHNOLOGIES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR DNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EREMID GENOMIC SERVICES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOVOGENE CO., LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Second Genome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metabiomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZIFO
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Realbio Technology (RBT) Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Microbiomics AS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rancho Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations